The effect of Activin A and Steroid Hormones on the Recurrent and single Abortion

Main Article Content

Nazar Ahmed Naji
Galawesh Norri Tahrr

Abstract

This study is designed to evaluate the relationship between Activin -A and the incidence of recurrent and single abortion. The study also included the Estimate of steroid hormones levels (FSH, LH and progesterone concentration through the abortion and normal pregnancy. The work performed through using 90 blood samples were taken from aborted and normal pregnant women their range ages between (15-45) years, attended Azadi teaching hospital in Kirkuk and general hospital of Kirkuk and some private medical clincs during the period from 1st of September (2012) to end of march (2013)


Results revealed a significant increase in the concentration of Activin A ,FSH in the group of recurrent and single aborted women in comparison with control group. There was a significant decrease the levels of progesterone  and in the group recurrent  and single aborted women in comparison with control group .


 

Article Details

How to Cite
Nazar Ahmed Naji, & Galawesh Norri Tahrr. (2023). The effect of Activin A and Steroid Hormones on the Recurrent and single Abortion. Tikrit Journal of Pure Science, 21(5), 97–103. https://doi.org/10.25130/tjps.v21i5.1035
Section
Articles

References

1. Guyton, A.C. and Hall, J.E .(2006). Text book of physiology.11th ed. Elsevier Saunders. China.pp:931-942

2. Stuart, C. and Christoph, I. (2002). Obstetrics by ten teachers.17th ed. Arnold pub. London

3. Chan, P.D. and Johnson, S.M.(2006).Current clinical Strategies Gynecology and Obestetrics

4. Arulkumaran , S.; Sivanesaratnam , V.; Chatterjee , A. and Kumar , P. (2004). Essentials of obstetrics. 1st ed. Jaypee Brothers medical pub. New Delhi. pp: 41-24.

5. Finer, L.B. and Henshaw ,S .K.;(2005); Abortion incidence and services. Perspect. Sex Reprod .Health, 35:6-15.

6. Creinin, M.D.; (2000); Medical abortion regimens: Historical context and Overview. A.M.J. obstet. Gynecol. pp: 183.

7. Rosenthan, E. (2007). Lagal or Not , Abortion Rates Compare. New York Times Retrieved .pp:30-36.

8. Sharp, M. and Crop D. (2009). Spontaneous Abortion (Miscarriage). a subsidiany of Merck & Co., Inc., Whitehouse Station ,N.J.

9. Hacker, N. F.; Moore, J. G. and Gambone, J. C. (2004). Essentials of obstetrics and gynecology. 4th ed. Elsevier Saunders. China . pp : 85-221

10. Burger HG, Igarashi M (April 1988). "Inhibin: definition and nomenclature, including related substances". The Journal of Clinical Endocrinology and Metabolism 66 (4): 885–6. PMID 3346366.

11. Ying S (1988) Inhibins, activins and follistatins: gonadal proteins modulatingthe secretion of follicle-stimulating hormone Endocrine Reviews 9267–293

12. petraglia, F.; Gallinelli, A.; Devita, D.; Lewis, K.; Mathews, L. and Vale, W. (1994). Activin at parturition changes of maternal serum levels and evidence for alocal effect on prostaglandin release, J. clin. Endo. Metab., 84: 278-82.

13. Luisi, S; Florio, P.; Reis, FM and petraglia, F. (2001) Expression and Secretion of activin-A :possible physiology and clinical implication. Eur., J. Endocrinol. 145:225-236.

14. Chen YG, Wang Q, Lin SL, Chang CD, Chuang J, Chung J,Ying SY (May 2006). "Activin signaling and its role in regulation of cell proliferation, apoptosis, and carcinogenesis". Exp. Biol. Med. (Maywood) 231 (5): 534–44. P16636301.

15. Sulyok S, Wankell M, Alzheimer C, Werner S (October 2004). "Activin: an important regulator of wound repair, fibrosis, and neuroprotection". Mol. Cell. Endocrinol. 225 (1–2): 127–32 doi: 10.1016/ j. mce. 2004.07.011. PMID 15451577.

16. Stamler R, Keutmann HT, Sidis Y, Kattamuri C, Schneyer A&Thompson TB2008 The structure of FSTL3.activin A complex: differential binding ofn-terminal domains influences follistatin - type antagonist specificity. Journal of Biologica Chemistry 283 32831–32838.

17. Florio, P.; severi, FM.; cobellis, L.; Danero, S.; Bome, A and Luisi, S. (2002). Serum activin-A and inhibin-A. Newclinical markers for hydatidi form mole. Cancer., 94: 2618-2622.

18. Muttukrishna, S.; North, R.A.; Morris, J.; Schellenberg, J.C.; Taylor, R.S.; Asselin, J.; Ledger, W.L. and Redman C.W.(2000).Serum inhibin-A and Activin-A are elevated prior to the onset of pre-eclampsia. Hum. Reprod.,15:1640-1645.

19. Blackburn, C.A.; Keelan , J.A.; Taylor, R.S.; North, R.A. (2003). Maternal serum activin-A is not elevated before preeclampsia in women who are at high risk. AM. J. Obstet.Gynecol.188:807-811.

20. Florio, P.; Luisi, S.; Ciarmela, P.; Severi, FM.; Bocchi, C. and petraglia, F. (2004). Inhibins and activins in pregnancy. Mol. Cell Endocrinol., 225 (1-2): 93-100.

21. Deli, A; Kreidl, E; Santifaller, S.; Trotter, B.; Seir, K.; Berger, W.; Schulte-Hermann, R; Rodgarkia - Dara, C. and Grusch, M. (2008). Acticins and activin antagonists in hepatocellular carcinoma. World, J. gastroen terol. 14(11):1699-709.

22. Lamba P, Santos MM, Philips DP & Bernard DJ 2006 Acute regulation of murine follicle-stimulating hormone beta subunit transcription by activin A. Journal of Molecular Endocrinology 36 201–220.

23. Klein, NA.; Houmard, BS.; Hansen, KR.; Brenda, S.; Woodruff, TK.; sluss, PM.; Bremner, WJ. and Michael, RS. (2004). Age-Related analysis of Inhibin -A, Inhibin-B and Activin-A relative to the Intercycle monotropic Follicle stimulating Hormone Rise in Normal Ovulatory Women. The Journal of clinical Endocrinology and Metabolism, Vol. (89), No. (6): 2977-2981.

24. Marya , R .K.(2003) .Medical physiology. 2nd ed. CBS Publishers and distributors NEWDELHI. BANGLORE. PP: 491- 503.

25. Dipiro and Harris, W. (2007) Pharmacitherapy Physiologie, J. Clin. Endo. &Meta. Vol.(82) p131.

26. Van Derlin , P.G.; Cekleniak , N.; Coutiforis , C.; Boyd , J. and Strauss , III , J. F.(1997) Evidence for the roligo clonal orgin of the granulose cell population of the mature human follical, J. Clin. Endo. & Metab. Vol.(82) p:3019.Adoshi, E.Y. (1994) Endocrinology of the ovarian, J. Hum. Reprod. Vol (5) p: 815-827.

27. Coulam, CB. and stern, JJ. (1994). Endocrine factors assoiated with recurrent spontaneous abortion. Clin. obstet. Gynecol., 37 (3): 730-44.

28. Blumenfeld, Z. and Ritter, M. (2006). Inhibin, Activin and follistatin in human Fetal pituitary and Gonadal physiology. Annals of the Newyork Academy of Sciences, Vol:943 (1): 34-48.

29. Warren, M. P. And Stiehl , A.L. (1999) . Exercise and female adolescents: effects on the reproductive and skeletal systems. Journal of the American Medical Women s Association 54(3): 115-120 .

30. Szekeres-Bartho, J.,; Halasz, M., and Palkovics, T.,; (2009); Progesterone in pregnancy, receptor-ligand interaction and signaling pathways; J. Reprod Immunol ;83: 60-4.

31. Ozlü T, Gungor AC, Donmez ME, Duran B. Use of progestogens in pregnant and infertile patients. Arch Gynecol Ostet. 2012; 286(2): 495-503.

32. Coomarasamy A, Truchanowicz EG, Rai R. Dose first trimester progesterone prophylaxis increase the live birth rate women with unexplained recurrent miscarriage. BMJ. 2011; 15(7): 305-308.

33. Nelson ,D.B.(2003).Does stress influence early pregnancy loss .Ann Epidemiol ,13 (4):223.

34.Chrestopher, R.; Susan, K.B. and Juhn, C.M. (2007). Progesterone acutely increases LH pulse amplitude but dos not acutely influence nocturnal LH pulse frequency slowing during the late follicular phase in women-AM. J. Physiol. Endocrinol Metab. 292: 900-9006.